Matthias Cavassini Selected Research

DNA (Deoxyribonucleic Acid)

3/2024	Genetic diversity from proviral DNA as a proxy for time since HIV-1 infection.
12/2022	Increased prevalence of clonal hematopoiesis of indeterminate potential amongst people living with HIV.
1/2022	The association between hepatitis B virus infection and nonliver malignancies in persons living with HIV: results from the EuroSIDA study.
11/2020	Increased CHIP Prevalence Amongst People Living with HIV.
1/2011	Early antiretroviral therapy during primary HIV-1 infection results in a transient reduction of the viral setpoint upon treatment interruption.
1/2011	Effect of early antiretroviral therapy during primary HIV-1 infection on cell-associated HIV-1 DNA and plasma HIV-1 RNA.
5/2008	Predicting the evolution of Kaposi sarcoma, in the highly active antiretroviral therapy era.
7/2004	HIV-1 co/super-infection in intravenous drug users.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Matthias Cavassini Research Topics

Disease

43	Infections 03/2024 - 07/2004
22	HIV Infections (HIV Infection) 02/2023 - 04/2004
12	Acquired Immunodeficiency Syndrome (AIDS) 10/2021 - 03/2005
9	Neoplasms (Cancer) 01/2022 - 02/2005
8	Coinfection 04/2024 - 07/2007
5	Dyslipidemias (Dyslipidemia) 01/2024 - 03/2007
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 07/2015
5	Viremia 10/2019 - 07/2004
4	Hepatitis B 04/2024 - 07/2007
4	Disease Progression 01/2022 - 07/2009
4	Obesity 01/2022 - 07/2007
4	Opportunistic Infections (Opportunistic Infection) 01/2020 - 01/2010
4	Hepatitis C 01/2015 - 01/2008
3	Body Weight (Weight, Body) 04/2024 - 01/2010
3	COVID-19 01/2024 - 10/2021
3	Hypertension (High Blood Pressure) 01/2024 - 04/2013
3	Inflammation (Inflammations) 05/2023 - 01/2013
3	Atherosclerosis 12/2022 - 11/2020
3	Osteoporosis 10/2019 - 01/2017
3	Neurocognitive Disorders (Clerambault Syndrome) 12/2017 - 01/2013
3	Anus Neoplasms (Anal Cancer) 01/2017 - 09/2013
3	Diabetes Mellitus 01/2017 - 01/2007
3	Drug-Related Side Effects and Adverse Reactions 01/2017 - 01/2011
3	Tuberculosis (Tuberculoses) 07/2014 - 01/2007
2	Weight Gain 04/2024 - 01/2020
2	Genetic Risk Score 01/2023 - 01/2020
2	Superinfection 01/2022 - 07/2014
2	Syphilis 10/2021 - 01/2020
2	Myocardial Infarction 02/2021 - 06/2012
2	Abdominal Obesity 01/2020 - 06/2012
2	Chronic Hepatitis C 10/2019 - 07/2013
2	Kaposi Sarcoma (Kaposi's Sarcoma) 11/2018 - 05/2008
2	Fibrosis (Cirrhosis) 10/2016 - 01/2014
2	Liver Diseases (Liver Disease) 09/2015 - 01/2014
2	Nausea 04/2015 - 07/2011
2	Alzheimer Disease (Alzheimer's Disease) 02/2013 - 01/2013
2	Hypersensitivity (Allergy) 05/2010 - 01/2008
2	Coronary Disease (Coronary Heart Disease) 01/2010 - 03/2007
1	Proctitis 03/2023
1	Chronic Renal Insufficiency 01/2023
1	B-Cell Lymphoma (Lymphoma, B Cell) 03/2022
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2022
1	Hepatitis D 01/2022

Drug/Important Bio-Agent (IBA)

15	RNA (Ribonucleic Acid)IBA 04/2024 - 05/2008
8	Tenofovir (Viread)FDA Link 04/2024 - 04/2008
8	DNA (Deoxyribonucleic Acid)IBA 03/2024 - 07/2004
7	NucleosidesIBA 10/2019 - 03/2007
7	Protease Inhibitors (Protease Inhibitor)IBA 07/2015 - 01/2007
6	LipidsIBA 04/2024 - 03/2007
6	AntibodiesIBA 01/2024 - 02/2005
6	VaccinesIBA 01/2022 - 07/2004
5	AntigensIBA 04/2024 - 05/2008
5	Reverse Transcriptase InhibitorsIBA 10/2019 - 07/2007
4	Hepatitis B Surface Antigens (HBsAg)FDA Link 04/2024 - 10/2016
4	tenofovir alafenamideIBA 04/2024 - 01/2016
4	CholesterolIBA 01/2024 - 03/2007
4	abacavir (Ziagen)FDA Link 01/2023 - 01/2008
4	dolutegravirIBA 01/2020 - 04/2015
3	InterferonsIBA 07/2023 - 01/2015
3	Broadly Neutralizing AntibodiesIBA 01/2022 - 11/2016
3	lamivudine drug combination abacavir FDA Link 10/2019 - 09/2010
3	NucleotidesIBA 01/2019 - 02/2011
3	Antiviral Agents (Antivirals)IBA 07/2018 - 01/2013
3	insulin receptor-related receptor (IRR)IBA 01/2017 - 07/2007
3	Raltegravir Potassium FDA Link 01/2017 - 07/2009
3	Ribavirin (Virazole)FDA LinkGeneric 09/2015 - 07/2013
3	efavirenz (Sustiva)FDA Link 07/2015 - 07/2011
3	Biomarkers (Surrogate Marker)IBA 07/2015 - 01/2014
3	EnzymesIBA 06/2014 - 01/2013
2	Triglycerides (Triacylglycerol)IBA 01/2024 - 06/2012
2	Anti-HIV Agents (AIDS Drugs)IBA 01/2022 - 01/2020
2	Alanine Transaminase (SGPT)IBA 01/2022 - 01/2008
2	Interferon LambdaIBA 11/2018 - 08/2014
2	Immunoglobulin G (IgG)IBA 01/2018 - 01/2013
2	Rivastigmine (Exelon)FDA LinkGeneric 12/2017 - 02/2013
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 10/2016 - 01/2014
2	Zidovudine (Retrovir)FDA LinkGeneric 12/2015 - 01/2010
2	Lamivudine (Epivir)FDA Link 12/2015 - 01/2010
2	Darunavir (Prezista)FDA Link 04/2015 - 07/2009
2	Ritonavir (Norvir)FDA Link 04/2015 - 04/2010
2	Atazanavir Sulfate (Reyataz)FDA Link 09/2012 - 11/2006
2	Opiate AlkaloidsIBA 09/2012 - 07/2011
2	Tuberculin (PPD)IBA 11/2011 - 01/2007
2	Nevirapine (Viramune)FDA Link 07/2011 - 01/2010
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2024
1	CytokinesIBA 07/2023
1	Interleukin-6 (Interleukin 6)IBA 05/2023
1	fibrin fragment D (D-dimer)IBA 05/2023
1	cabotegravirIBA 02/2023
1	Rilpivirine (TMC-278)IBA 02/2023
1	A-Form DNA (A-DNA)IBA 01/2023
1	Viral RNAIBA 01/2023
1	FibrinIBA 03/2022
1	Surface Antigens (Surface Antigen)IBA 01/2022
1	Fluspirilene (Imap)IBA 01/2022

Therapy/Procedure

39	Therapeutics 04/2024 - 06/2004
21	Highly Active Antiretroviral Therapy (HAART) 11/2018 - 04/2004
14	Art Therapy 04/2024 - 03/2007
1	Aftercare (After-Treatment) 03/2023
1	Injections 02/2023